Phase 2 pharmacological study of pemetrexed administered with cisplatin and a vitamin supplement in patients with nonresectable pleural mesothelioma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Cyanocobalamin; Pemetrexed
- Indications Mesothelioma
- Focus Pharmacogenomic; Therapeutic Use
- 17 May 2011 Biomarkers information updated
- 16 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 16 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.